Cerevel Therapeutics Holdings, Inc.
CERE · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $320 | $991 | $156 | $176 |
| Short-Term Investments | $526 | $0 | $521 | $561 |
| Receivables | $5 | $5 | $3 | $4 |
| Inventory | $0 | $0 | -$3 | $0 |
| Other Curr. Assets | $8 | $11 | $7 | $11 |
| Total Curr. Assets | $860 | $1,007 | $688 | $752 |
| Property Plant & Equip (Net) | $45 | $46 | $47 | $48 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $219 | $187 | $81 | $89 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $3 | $6 | $6 |
| Total NC Assets | $268 | $236 | $134 | $143 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,127 | $1,243 | $822 | $894 |
| Liabilities | – | – | – | – |
| Payables | $11 | $12 | $12 | $9 |
| Short-Term Debt | $4 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$4 | $0 | $0 | $0 |
| Other Curr. Liab. | $70 | $77 | $64 | $53 |
| Total Curr. Liab. | $84 | $92 | $79 | $66 |
| LT Debt | $365 | $365 | $366 | $366 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $114 | $112 | $105 | $112 |
| Total NC Liab. | $479 | $477 | $470 | $478 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $30 | $28 | $29 | $30 |
| Total Liabilities | $563 | $570 | $549 | $544 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,533 | -$1,401 | -$1,268 | -$1,172 |
| AOCI | -$1 | $2 | $2 | $1 |
| Other Equity | $2,098 | $2,073 | $1,539 | $1,521 |
| Total Equity | $564 | $674 | $273 | $351 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,127 | $1,243 | $822 | $894 |
| Net Debt | $48 | -$622 | $213 | $193 |